Stephen F. Flatt - Mar 5, 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen F. Flatt by Kristina R. Hulsey, POA
Stock symbol
NHC
Transactions as of
Mar 5, 2025
Transactions value $
$0
Form type
4
Date filed
3/6/2025, 06:17 PM
Previous filing
Feb 26, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Award $0 +2.91K +5.33% $0.00 57.6K Mar 5, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NHC Option to Purchase Common Stock 4.73K Mar 5, 2025 Common Stock 4.73K $63.96 Direct
holding NHC Option to Purchase Common Stock 10K Mar 5, 2025 Common Stock 10K $53.94 Direct
holding NHC Option to Purchase Common Stock 15K Mar 5, 2025 Common Stock 15K $94.10 Direct
holding NHC Option to Purchase Common Stock 18K Mar 5, 2025 Common Stock 18K $90.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028.